Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

3-bromocinnamamide

Known as: 3-(3-bromophenyl)-2-propenamide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
  • E. Lane, R. Levy
  • Journal of Pharmacokinetics and Biopharmaceutics
  • 2005
  • Corpus ID: 33073678
A previous study of the metabolic fate of cinromide (3-bromo-N-ethylcinnamamide) in rhesus monkey established that half of a dose… Expand
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1983
1983
Summary: The effect of the experimental anticonvulsant cinromide (3‐bromo‐N‐ethylcinnamamide) on various inhibitory and… Expand
1983
1983
  • E. Lane, R. Levy
  • Journal of pharmaceutical sciences
  • 1983
  • Corpus ID: 20963912
Fifty percent of a cinromide dose was metabolized to an active metabolite in the rhesus monkey. The steady-state concentration of… Expand
1980
1980
Summary: In a previous study (Lockard et al., 1979) Cinromide (3 bromo‐N‐ethylcinnamamide), an experimental anticonvulsant… Expand
1980
1980
A quantitative thin-layer chromatography (TLC) procedure is described for the analysis of cinromide (3-bromo-N-ethylcinnamamide… Expand
1979
1979
A high-performance liquid chromatographic method is described for monitoring plasma concentrations of cinromide (3-bromo-N… Expand